Dual bronchodilators in chronic obstructive pulmonary disease: Evidence from randomized controlled trials and real-world studies
Purpose: Dual bronchodilator therapy with a long-acting muscarinic antagonist (LAMA) and a long-acting β2-agonist (LABA) is recommended in the pharmacological management of chronic obstructive pulmonary disease (COPD) according to the Global Initiative for Chronic Obstructive Lung Disease. To better...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-11-01
|
| Series: | Respiratory Medicine: X |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590143520300038 |